Crop Life Science Appoints Mr. Pareshbhai Bhagvanbhai Parsana as Additional Independent Director

Crop Life Science Appoints Mr. Pareshbhai Bhagvanbhai Parsana as Additional Independent Director

Crop Life Science Appoints Mr. Pareshbhai Bhagvanbhai Parsana as Additional Independent Director​

Crop Life Science Limited has appointed Mr. Pareshbhai Bhagvanbhai Parsana as an Additional (Independent) Director of the company. The appointment was made by the Board of Directors during a meeting held on July 30, 2026, and he is set to hold the position effective from the same date.

The board has appointed Mr. Parsana, who is noted for his professional expertise, extensive business experience, and sound knowledge of corporate management. The company anticipates that his analytical approach and valuable guidance will significantly contribute to strengthening the effectiveness of the Board and supporting the company's strategic direction.

Mr. Pareshbhai Bhagvanbhai Parsana has been appointed to hold office as the Additional (Independent) Director for a period of five years, subject to regularization by the shareholders. The appointment confirms his status as an Independent Director in relation to the company.

Key details regarding the appointment are summarized below:

DetailInformation
Director NameMr. Pareshbhai Bhagvanbhai Parsana
RoleAdditional (Independent) Director
Date of AppointmentJuly 30, 2026
TenureFive years, subject to regularization by shareholders
Profile HighlightsAged 44 years; possesses extensive business experience and sound knowledge of corporate management.

CLSL Stock Price Movement​

Today, Crop Life Science Limited shares surged in the market, closing at ₹66.00 after gaining 6.45% on a robust trading session. The equity traded for 16,000 shares during the session as it continued its upward trajectory.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top